UNSPSC 51422429: Hydrocortisone cypionate

This classification denotes an anti-inflammatory agent with the molecular formula C29H42O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4XDY25L70B, chemically known as pregn-4-ene-3,20-dione, 21-(3-cyclopentyl-1-oxopropoxy)-11,17-dihydroxy-, (11.beta.)-, but more generally known as hydrocortisone cypionate, which bears US NIH Compound Identifier 10508. European Medicines Agency schedules hydrocortisone cypionate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08065MIG.

Most nations, for tariff purposes, schedule hydrocortisone cypionate under HS 29372100. Hydrocortisone cypionate bears US NLM identifiers UMLS ID C0612688 and NCI Concept Code C65864. SMILES: C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC5CCCC5)O)C)O.

UNSPSC 51422429 Hydrocortisone cypionate is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities tagged under it involve procurement of naloxone and drug deactivation systems, as well as direct-to-manufacturer pharmacy benefit program services—scope items that diverge substantially from the code's nominal pharmaceutical product. The mismatch between the code definition and the actual solicitations suggests this Commodity code shows little relevant recent activity aligned with its stated scope, and the opportunities presently recorded may reflect tagging inconsistencies rather than genuine demand for hydrocortisone cypionate in state and local procurement.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, while the Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program—neither of which aligns with the hydrocortisone cypionate product category. The Seminole County IFB included a response deadline of July 26, 2023 (predating the posting date by several years, indicating a data inconsistency), with requirements for E-Verify compliance, drug-free workplace certification, and potential FEMA funding compliance. The Texas RFI, closing April 3, 2026, was exploratory in nature, designed to inform future formal procurement strategy rather than to issue binding awards. Without additional solicitations properly tagged to this Commodity code, there is insufficient current activity to characterize issuing-body concentration, geographic spread, or meaningful business development opportunity in hydrocortisone cypionate procurement at the state and local level.